Research and Development
The company makes scientific efforts in several directions. We consider it important to use all the potential of phytomedecine and confirm this potential based on reliable scientific research. That is why we cooperate with top-level scientific centers and conduct large-scale preclinical and clinical tests of our products.
Our scientific efforts are made in the following directions:
-
Oncological diseases. Our unique BAD “Flavopersin” was successfully tested in the Russian Oncological Research Center in Moscow. The test results confirmed a clear anticancer activity of this BAD. A particular attention was paid to how this BAD treats lymphatic leukemia cells, the center’s experts recommended to further examine and test the BAD as anticancer drug.
-
Diabetes and metabolic syndrome. Our unique BAD “Bereginya” made of birch leaves’ extract confirmed its efficiency in screening laboratory examinations. This product really has a clear sugar-lowering activity. We continue clinical and preclinical testing of this BAD.
-
Normalization of gut organisms. Our BAD “Floraluks” was designed for prevention and correction of dysbacteriosis. The BAD is composed of rye bran (prebiotic component) and fermented lactobacilli (probiotic component). We had conducted various preclinical and clinical tests which confirmed a high complex efficiency of this product. “Floraluks” has clear sorption and probiotic activities. It suppresses pathogenic bacteria and is great source of dietary fibers.